Erratum to: BK Polyomavirus Infection and Renourinary Tumorigenesis (American Journal of Transplantation, (2016), 16, 2, (398-406), 10.1111/ajt.13550);BK Polyomavirus Infection and Renourinary Tumorigenesis

American Journal of Transplantation

Volumn 16, Issue 2, 2016, Pages 398-406

  Papadimitriou, John C ^a   Randhawa, P ^b   Rinaldo, C Hanssen ^c   Drachenberg, C B ^a   Alexiev, B ^a   Hirsch, H H ^d,e,f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

cancer; cancer malignancy neoplasia; clinical research practice; histopathology; infection and infectious agents, viral, infection and infectious agents, viral: BK JC polyoma; infectious disease; kidney transplantation; malignancy neoplasia risk factors; nephrology pathology

Indexed keywords

PRB PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN;

BK VIRUS INFECTION; BLADDER TUMOR; CANCER GRADING; CANCER INHIBITION; CANCER RISK; CANCER TRANSPLANTATION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENOMIC INSTABILITY; GRAFT RECIPIENT; HUMAN; MERKEL CELL POLYOMAVIRUS; METASTASIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RENOURINARY CARCINOGENESIS; REVIEW; VIRUS MUTATION; BK VIRUS; COMPLICATION; KIDNEY DISEASES; PATHOGENICITY; PATHOLOGY; POLYOMAVIRUS INFECTION; PROGNOSIS; URINARY BLADDER NEOPLASMS; VIROLOGY; VIRUS INFECTION;

BK VIRUS; CARCINOGENESIS; HUMANS; KIDNEY DISEASES; POLYOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS;

EID: 84957974143     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.14098     Document Type: Erratum

References (69)

1. Vajdic CM, van Leeuwen MT., Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747-1754.
2. Sherston SN, Carroll RP, Harden PN, Wood KJ., Predictors of cancer risk in the long-term solid-organ transplant recipient. Transplantation 2014; 97: 605-611.
3. Spurgeon ME, Lambert PF., Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential. Virology 2013; 435: 118-130.
4. Kamal MM, Soliman SM, Shokeir AA, Abol-Enein H, Ghoneim MA., Bladder carcinoma among live-donor renal transplant recipients: A single-centre experience and a review of the literature. BJU Int 2008; 101: 30-35.
5. Rogers A, Ng JK, Glendinning J, Rix D., The management of transitional cell carcinoma (TCC) in a European regional renal transplant population. BJU Int 2012; 110: E34-E40.
6. Tsaur I, Karalis A, Blaheta R, et al., Transitional cell carcinoma of the native urinary tract after kidney transplantation: Recommendations following a long-term retrospective analysis. Am J Med Sci 2011; 341: 478-483.
7. Li HZ, Xia M, Han Y, Xu XG, Zhang YS., De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China. Urol Int 2009; 83: 200-205.
8. Dalianis T, Hirsch HH., Human polyomaviruses in disease and cancer. Virology 2013; 437: 63-72.
9. Abend JR, Jiang M, Imperiale MJ., BK virus and human cancer: Innocent until proven guilty. Semin Cancer Biol 2009; 19: 252-260.
10. Dalianis T, Hirsch HH., BK polyomavirus and transformation. In:, Robertson E, editor. Cancer Associated Viruses. New York, NY: Springer, 2012; p. 419-432.
11. Bethge T, Hachemi HA, Manzetti J, et al., Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression. J Virol 2015; 89: 3396-3411.
12. Chen CH, Wen MC, Wang M, et al., High incidence of malignancy in polyomavirus-associated nephropathy in renal transplant recipients. Transplant Proc 2010; 42: 817-818.
13. Wang HH, Liu KL, Chu SH, et al., BK virus infection in association with posttransplant urothelial carcinoma. Transplant Proc 2009; 41: 165-166.
14. Weinreb DB, Desman GT, Amolat-Apiado MJ, et al., Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopatho 2006; 34: 201-203.
15. Fioriti D, Pietropaolo V, Dal Forno S, et al., Urothelial bladder carcinoma and viral infections: Different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003; 16: 283-288.
16. Monini P, Rotola A, Di Luca D, et al., DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology 1995; 214: 273-279.
17. Bulut Y, Ozdemir E, Ozercan HI, et al., Potential relationship between BK virus and renal cell carcinoma. J Med Virol 2013; 85: 1085-1089.
18. Rollison DE, Sexton WJ, Rodriguez AR, et al., Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer 2007; 120: 1248-1251.
19. Polesel J, Gheit T, Talamini R, et al., Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 2012; 106: 222-226.
20. Robles C, Viscidi R, Malats N, et al., Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: The Spanish Bladder Cancer Study. Int J Cancer 2013 Jan 25.
21. Newton R, Ribeiro T, Casabonne D, et al., Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. Br J Cancer 2005; 93: 1305-1306.
22. Alexiev BA, Drachenberg CB, Papadimitriou JC., Polyomavirus-cystitis associated with in situ and invasive urothelial carcinoma in a heart transplant recipient: Evidence suggesting sequential progression/evolution from infection to carcinoma. Transplantation 2015; 99: e3-e4.
23. Alexiev BA, Papadimitriou JC, Chai TC, et al., Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: A case report. Pathology, research and practice 2013 Mar 4.
24. Alexiev BA, Randhawa P, Vazquez Martul E, et al., BK virus-associated urinary bladder carcinoma in transplant recipients: Report of 2 cases, review of the literature, and proposed pathogenetic model. Hum Pathol 2013 Jan 11.
25. Bialasiewicz S, Cho Y, Rockett R, et al., Association of micropapillary urothelial carcinoma of the bladder and BK viruria in kidney transplant recipients. Transpl Infect Dis 2013 Apr 1.
26. Dufek S, Haitel A, Muller-Sacherer T, Aufricht C., Duct Bellini carcinoma in association with BK virus nephropathy after lung transplantation. J Heart Lung Transplant 2013; 32: 378-379.
27. Emerson LL, Carney HM, Layfield LJ, Sherbotie JR., Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study. Pediatr Transplant 2008; 12: 600-605.
28. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH., Bladder carcinoma in a transplant recipient: Evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73: 1933-1936.
29. Hill P, Goodman D., High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection. Nephrol Dial Transpl 2009; 2: 246-249.
30. Li JY, Fang D, Yong TY, et al., Transitional cell carcinoma in a renal allograft with BK nephropathy. Transpl Infect Dis 2013; 15: E270-E272.
31. McDaid J, Farkash EA, Steele DJ, et al., Transitional cell carcinoma arising within a pediatric donor renal transplant in association with BK nephropathy. Transplantation 2013; 95: e28-e30.
32. Fujita T, et al., BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: A case report. Transplant Proc 2014; 46: 616-619.
33. Pino L, Rijo E, Nohales G, et al., Bladder transitional cell carcinoma and BK virus in a young kidney transplant recipient. Transpl Infect Dis 2013; 15: E25-E27.
34. Roberts IS, Besarani D, Mason P, et al., Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer 2008; 99: 1383-1386.
35. Saleeb R, Faragalla H, Yousef GM, Stewart R, Streutker CJ., Malignancies arising in allograft kidneys, with a first reported translocation RCC post-transplantation: A case series. Pathol Res Pract 2015; 211: 584-587.
36. Saquib R, Saad R, Savino DA, et al., Transitional cell carcinoma of renal allograft associated with BK virus infection. Dialysis Transpl 2009; 38: 518-519.
37. van Aalderen MC, Yapici U, van der Pol JA, et al., Polyomavirus BK in the pathogenesis of bladder cancer. Neth J Med 2013; 71: 26-28.
38. Grippo PJ, Sandgren EP., Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 2000; 157: 805-813.
39. Zhang ZT, Pak J, Shapiro E, Sun TT, Wu XR., Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res 1999; 59: 3512-3517.
40. Al Hussain TO, Akhtar M,. Molecular basis of urinary bladder cancer. Adv Anat Pathol 2013; 20: 53-60.
41. Loghavi S, Bose S., Polyomavirus infection and urothelial carcinoma. Diagn Cytopathol 2011; 39: 531-535.
42. Alexiev BA, Papadimitriou JC, Drachenberg CB., BK polyomavirus-infected nephrogenic adenoma of the urinary bladder in a renal transplant recipient: A case report. Pathol Res Pract 2015; 211: 697-701.
43. Gosert R, Rinaldo CH, Funk GA, et al., Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205: 841-852.
44. Hanahan D, Weinberg RA., Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
45. Moens U, Van Ghelue M, Johannessen M., Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci 2007; 64: 1656-1678.
46. Sherr CJ, McCormick F., The RB and p53 pathways in cancer. Cancer cell 2002; 2: 103-112.
47. Atencio IA, Shadan FF, Zhou XJ, Vaziri ND, Villarreal LP., Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 1993; 67: 1424-1432.
48. Mitterhofer AP, Tinti F, Pietropaolo V, et al., Polyomavirus BK replication in adult polycystic kidney disease post-renal transplant patients and possible role of cellular permissivity. Transplant Proc 2011; 43: 1048-1051.
49. Kawatani M, Imoto M., Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashion. J Biol Chem 2003; 278: 19732-19742.
50. Kolzau T, Hansen RS, Zahra D, Reddel RR, Braithwaite AW., Inhibition of SV40 large T antigen induced apoptosis by small T antigen. Oncogene 1999; 18: 5598-5603.
51. Carbone M, Burck C, Rdzanek M, et al., Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation. Cancer Res 2003; 63: 6125-6129.
52. Foddis R, De Rienzo A, Broccoli D, et al., SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21: 1434-1442.
53. Catalano A, Romano M, Martinotti S, Procopio A., Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Oncogene 2002; 21: 2896-2900.
54. Mannon RB, Hoffmann SC, Kampen RL, et al., Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 2005; 5: 2883-2893.
55. Hanahan D, Coussens LM., Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322.
56. Pagano JS, Blaser M, Buendia MA, et al., Infectious agents and cancer: Criteria for a causal relation. Semin Cancer Biol 2004; 14: 453-471.
57. Verhalen B, Justice JL, Imperiale MJ, Jiang M., Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection. J Virol 2015; 89: 5032-5039.
58. Maginnis MS, Atwood WJ., JC virus: an oncogenic virus in animals and humans ? Semin Cancer Biol 2009; 19: 261-269.
59. Shen CH, Wu JD, Hsu CD, et al., The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan. J Med Virol 2011; 83: 2191-2199.
60. Kipp BR, Sebo TJ, Griffin MD, Ihrke JM, Halling KC., Analysis of polyomavirus-infected renal transplant recipients' urine specimens: Correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysis. Am J Clin Pathol 2005; 124: 854-861.
61. Seemayer CA, Seemayer NH, Durmuller U, et al., BK virus large T and VP-1 expression in infected human renal allografts. Nephrol Dialysis Transpl 2008; 23: 3752-3761.
62. Todorovic B, Hung K, Massimi P, et al., Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor. J Virol 2012; 86: 13313-13323.
63. Ziemke P, Marquardt K, Griesser H., Predictive value of the combined p16 and Ki-67 immunocytochemistry in low-grade squamous intraepithelial lesions. Acta Cytol 2014; 58: 489-494.
64. Olthof NC, Speel EJ, Kolligs J, et al., Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PloS ONE 2014; 9: e88718.
65. zur Hausen H,. Viruses in human cancers. Science 1991; 254: 1167-1173.
66. zur Hausen H,. SV40 in human cancers: An endless tale ? Int J Cancer 2003; 107: 687.
67. Bouvard V, Baan RA, Grosse Y, et al., Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol 2012; 13: 339-340.
68. Houben R, Grimm J, Willmes C, et al., Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis. J Invest Dermatol 2012; 132: 254-256.
69. Kenan DJ, Mieczkowski PA, Burger-Calderon R, et al., The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome. J Pathol 2015; 237: 379-389.